Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
6.56
-0.25 (-3.67%)
At close: Mar 20, 2026, 4:00 PM EDT
6.57
+0.01 (0.15%)
After-hours: Mar 20, 2026, 4:10 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $150.64 million as of March 20, 2026.
Market Cap
150.64M
Enterprise Value
75.18M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $150.64M, a decrease of -29.78%. That is a compound annual growth rate of -29.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 122.87M | -22.16% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProMIS Neurosciences | 157.83M |
| Connect Biopharma Holdings | 157.09M |
| Sagimet Biosciences | 157.06M |
| Korro Bio | 155.04M |
| Corbus Pharmaceuticals Holdings | 152.53M |
| Nkarta | 152.00M |
| Vaxart | 151.84M |
| Heron Therapeutics | 146.80M |